HUTCHMED (SEHK:13) Announces Vesting of LTIP Awards

Bulletin Express
10/21

On October 21, 2025, HUTCHMED (China) Limited published an announcement regarding the vesting of certain non-performance based awards granted on October 20, 2021, under its Long Term Incentive Plan. According to the announcement, the awards vested on October 20, 2025.

The directors named in the announcement—Non-executive Director Dr. Dan Eldar, Non-executive Director Ms. Edith Shih, and Independent Non-executive Director Professor Tony Mok—each received 1,938 American depositary shares (ADS). For Ms. Shih, the ADS were issued to her employer, Hutchison International Limited. HUTCHMED is a commercial-stage biopharmaceutical company focused on targeted therapies and immunotherapies for cancer and immunological diseases. Further details appear in the official announcement dated October 21, 2025.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10